Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.47 -1.29 (-0.88%)
Streaming Delayed Price Updated: 10:22 AM EDT, Jun 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 914,878
Open 147.06
Bid (Size) 145.45 (1)
Ask (Size) 145.48 (1)
Prev. Close 146.76
Today's Range 145.37 - 147.21
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Johnson & Johnson To Pay $700M To Settle Multi-State Talc Investigation
Although the settlement has been reached, Johnson & Johnson still faces a substantial number of talc-related lawsuits. 
Via Benzinga

Performance

YTD
-9.06%
-9.06%
1 Month
-3.80%
-3.80%
3 Month
-10.61%
-10.61%
6 Month
-6.19%
-6.19%
1 Year
-9.02%
-9.02%

More News

Read More
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks You Can Safely Hold for the Long Haul
Via The Motley Fool
7 Recession-Proof Stocks to Buy Now for Peace of Mind
Via InvestorPlace
Uncovering Dividend Opportunities with NYSE:JNJ.
Via Chartmill
Performance Comparison: Johnson & Johnson And Competitors In Pharmaceuticals Industry
Via Benzinga
The 3 Most Undervalued Robinhood Stocks to Buy in June 2024
Via InvestorPlace
Time to Pounce: 2 High-Yielding Dow Stocks That Are Begging to Be Bought Right Now
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns
Via InvestorPlace
3 Stocks to Buy With 20% Upside
Via The Motley Fool
The 3 Best Dow Stocks to Buy in June 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Via InvestorPlace
3 Dow Stocks That Are No-Brainer Buys in June
Via The Motley Fool
Topics Stocks
Exposures US Equities
Sleep Easy: 3 Safe Stocks That Won’t Have You Stressin’
Via InvestorPlace
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
The 3 Most Undervalued Dow Stocks to Buy in June 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June
Via InvestorPlace
Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained Deep, Durable Responses In Pretreated Patients
Via Benzinga
7 Overlooked Stocks That Belong in Every Portfolio
Via InvestorPlace
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 Magnificent Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever
Via InvestorPlace
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.